16870653

Source:http://linkedlifedata.com/resource/pubmed/id/16870653

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0027686, umls-concept:C0087111, umls-concept:C0154778, umls-concept:C0175668, umls-concept:C0796392, umls-concept:C1135130, umls-concept:C1517572, umls-concept:C1656863
pubmed:issue	2
pubmed:dateCreated	2007-1-24
pubmed:abstractText	To evaluate the safety and efficacy of intravitreal bevacizumab (Avastin) as treatment for subfoveal choroidal neovascularisation (CNV) due to pathological myopia.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/16870653-10424308, http://linkedlifedata.com/resource/pubmed/commentcorrection/16870653-10571338, http://linkedlifedata.com/resource/pubmed/commentcorrection/16870653-10721956, http://linkedlifedata.com/resource/pubmed/commentcorrection/16870653-11162982, http://linkedlifedata.com/resource/pubmed/commentcorrection/16870653-11162984, http://linkedlifedata.com/resource/pubmed/commentcorrection/16870653-11320011, http://linkedlifedata.com/resource/pubmed/commentcorrection/16870653-11476674, http://linkedlifedata.com/resource/pubmed/commentcorrection/16870653-11520751, http://linkedlifedata.com/resource/pubmed/commentcorrection/16870653-11931787, http://linkedlifedata.com/resource/pubmed/commentcorrection/16870653-12429239, http://linkedlifedata.com/resource/pubmed/commentcorrection/16870653-12689884, http://linkedlifedata.com/resource/pubmed/commentcorrection/16870653-12714395, http://linkedlifedata.com/resource/pubmed/commentcorrection/16870653-12867382, http://linkedlifedata.com/resource/pubmed/commentcorrection/16870653-15175435, http://linkedlifedata.com/resource/pubmed/commentcorrection/16870653-15936441, http://linkedlifedata.com/resource/pubmed/commentcorrection/16870653-16156152, http://linkedlifedata.com/resource/pubmed/commentcorrection/16870653-16156153, http://linkedlifedata.com/resource/pubmed/commentcorrection/16870653-16458968, http://linkedlifedata.com/resource/pubmed/commentcorrection/16870653-17244654, http://linkedlifedata.com/resource/pubmed/commentcorrection/16870653-6084222, http://linkedlifedata.com/resource/pubmed/commentcorrection/16870653-6195574
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0421041
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Angiogenesis Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized, http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A, http://linkedlifedata.com/resource/pubmed/chemical/bevacizumab
pubmed:status	MEDLINE
pubmed:month	Feb
pubmed:issn	0007-1161
pubmed:author	pubmed-author:DukerJay SJS, pubmed-author:ReichelEliasE, pubmed-author:RogersAdam HAH, pubmed-author:YamamotoIzumiI, pubmed-author:YatesPaul APA
pubmed:issnType	Print
pubmed:volume	91
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	157-60
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:16870653-Adult, pubmed-meshheading:16870653-Aged, pubmed-meshheading:16870653-Angiogenesis Inhibitors, pubmed-meshheading:16870653-Antibodies, Monoclonal, pubmed-meshheading:16870653-Antibodies, Monoclonal, Humanized, pubmed-meshheading:16870653-Choroidal Neovascularization, pubmed-meshheading:16870653-Drug Evaluation, pubmed-meshheading:16870653-Female, pubmed-meshheading:16870653-Humans, pubmed-meshheading:16870653-Injections, pubmed-meshheading:16870653-Male, pubmed-meshheading:16870653-Middle Aged, pubmed-meshheading:16870653-Myopia, Degenerative, pubmed-meshheading:16870653-Recurrence, pubmed-meshheading:16870653-Retrospective Studies, pubmed-meshheading:16870653-Treatment Outcome, pubmed-meshheading:16870653-Vascular Endothelial Growth Factor A, pubmed-meshheading:16870653-Visual Acuity, pubmed-meshheading:16870653-Vitreous Body
pubmed:year	2007
pubmed:articleTitle	Intravitreal bevacizumab (Avastin) as treatment for subfoveal choroidal neovascularisation secondary to pathological myopia.
pubmed:affiliation	New England Eye Center, Tufts University School of Medicine, Tufts-New England Medical Center, 750 Washington Street, Box 450, Boston, MA 02111, USA.
pubmed:publicationType	Journal Article, Case Reports